Company: SMNR
Filing Date: 2025-05-16
Form Type: 10-Q
Source: 0001213900-25-044889
Chunk: 226

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-05-16
Form: 10-Q
Item: Part II, Item 6
Chunk 226
---
, thereunto duly authorized.

    Date: May 16, 2025
    DENALI CAPITAL ACQUISITION CORP.

    By:
    /s/ Lei Huang

    Chief Executive Officer

    (Principal Executive Officer)

    By:
    /s/ You “Patrick” Sun

    Chief Financial Officer

    (Principal Financial and Accounting Officer)

40

NONE
NONE
NONE

0001913577
false
Q1
--12-31

    0001913577

    2025-01-01
    2025-03-31

    0001913577
    
      deca:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneRedeemableWarrantMember

    2025-01-01
    2025-03-31

    0001913577
    
      deca:ClassAOrdinarySharesParValue00001PerShareMember

    2025-01-01
    2025-03-31

    0001913577
    
      deca:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember

    2025-01-01
    2025-03-31

    0001913577
    
      us-gaap:CommonClassAMember

    2025-05-13

    0001913577
    
      us-gaap:CommonClassBMember

    2025-05-13

    0001913577

    2025-03-31

    0001913577

    2024-12-31

    0001913577
    
      us-gaap:RelatedPartyMember

    2025-03-31

    0001913577
    
      us-gaap:RelatedPartyMember

    2024-12-31

    0001913577
    
      us-gaap:CommonClassAMember

    2025-03-31

    0001913577
    
      us-gaap:CommonClassAMember

    2024-12-31

    0001913577
    
      us-gaap:CommonClassBMember

    2025-03-31

    0001913577
    
      us-gaap:CommonClassBMember

    202